{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:23Z","timestamp":1790007263851,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00296-021-04935-y","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T09:02:47Z","timestamp":1625216567000},"page":"1617-1624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-3905","authenticated-orcid":false,"given":"D\u00f6nd\u00fc","family":"\u00dcsk\u00fcdar Cansu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-4580","authenticated-orcid":false,"given":"Hava","family":"\u00dcsk\u00fcdar Teke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2606-1103","authenticated-orcid":false,"given":"G\u00fcven Bar\u0131\u015f","family":"Cansu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-0699","authenticated-orcid":false,"given":"Cengiz","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"4935_CR1","volume-title":"Williams hematology","author":"K Kaushansky","year":"2016","unstructured":"Kaushansky K (2016) Williams hematology, 9th edn. McGraw-Hill, NewYork","edition":"9"},{"issue":"5","key":"4935_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1039\/c4ib00025k","volume":"6","author":"E Pretorius","year":"2014","unstructured":"Pretorius E, Kell DB (2014) Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr Biol (Camb) 6(5):486\u2013510. https:\/\/doi.org\/10.1039\/c4ib00025k","journal-title":"Integr Biol (Camb)"},{"issue":"9","key":"4935_CR3","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/jemt.22047","volume":"75","author":"B Lipinski","year":"2012","unstructured":"Lipinski B, Pretorius E, Oberholzer HM, Van Der Spuy WJ (2012) Iron enhances generation of fibrin fibers in human blood: implications for pathogenesis of stroke. Microsc Res Tech 75(9):1185\u20131190. https:\/\/doi.org\/10.1002\/jemt.22047","journal-title":"Microsc Res Tech"},{"issue":"3","key":"4935_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bjh.15166","volume":"181","author":"JO Cullis","year":"2018","unstructured":"Cullis JO, Fitzsimons EJ, Griffiths WJ, Tsochatzis E, Thomas DW, British Society for H (2018) Investigation and management of a raised serum ferritin. Br J Haematol 181(3):331\u2013340. https:\/\/doi.org\/10.1111\/bjh.15166","journal-title":"Br J Haematol"},{"issue":"10","key":"4935_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/10245332.2018.1488569","volume":"23","author":"H Senjo","year":"2018","unstructured":"Senjo H, Higuchi T, Okada S, Takahashi O (2018) Hyperferritinemia: causes and significance in a general hospital. Hematology 23(10):817\u2013822. https:\/\/doi.org\/10.1080\/10245332.2018.1488569","journal-title":"Hematology"},{"issue":"5","key":"4935_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/ajcp\/aqw053","volume":"145","author":"K Sackett","year":"2016","unstructured":"Sackett K, Cunderlik M, Sahni N, Killeen AA, Olson AP (2016) Extreme Hyperferritinemia: Causes and Impact on Diagnostic Reasoning. Am J Clin Pathol 145(5):646\u2013650. https:\/\/doi.org\/10.1093\/ajcp\/aqw053","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"4935_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/imj.12768","volume":"45","author":"AJ Wormsbecker","year":"2015","unstructured":"Wormsbecker AJ, Sweet DD, Mann SL, Wang SY, Pudek MR, Chen LY (2015) Conditions associated with extreme hyperferritinaemia (>3000 mug\/L) in adults. Intern Med J 45(8):828\u2013833. https:\/\/doi.org\/10.1111\/imj.12768","journal-title":"Intern Med J"},{"issue":"5","key":"4935_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jclinpath-2012-201090","volume":"66","author":"MA Crook","year":"2013","unstructured":"Crook MA, Walker PL (2013) Extreme hyperferritinaemia; clinical causes. J Clin Pathol 66(5):438\u2013440. https:\/\/doi.org\/10.1136\/jclinpath-2012-201090","journal-title":"J Clin Pathol"},{"issue":"6","key":"4935_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","volume":"19","author":"C Moore Jr","year":"2013","unstructured":"Moore C Jr, Ormseth M, Fuchs H (2013) Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol 19(6):324\u2013328. https:\/\/doi.org\/10.1097\/RHU.0b013e31829ce01f","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"4935_CR10","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A, Fogerty A, Massarotti E, Neuberg D, Berliner N (2015) Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125(10):1548\u20131552. https:\/\/doi.org\/10.1182\/blood-2014-10-602607","journal-title":"Blood"},{"key":"4935_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1398.044","volume":"1109","author":"H Orbach","year":"2007","unstructured":"Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385\u2013400. https:\/\/doi.org\/10.1196\/annals.1398.044","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"4935_CR12","doi-asserted-by":"publisher","first-page":"e23618","DOI":"10.1002\/jcla.23618","volume":"34","author":"L Cheng","year":"2020","unstructured":"Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y (2020) Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Lab Anal 34(10):e23618. https:\/\/doi.org\/10.1002\/jcla.23618","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"4935_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"4935_CR14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.3390\/jcm10092008","volume":"10","author":"M Sandnes","year":"2021","unstructured":"Sandnes M, Ulvik RJ, Vorland M, Reikvam H (2021) Hyperferritinemia-A clinical overview. J Clin Med 10(9):2008. https:\/\/doi.org\/10.3390\/jcm10092008","journal-title":"J Clin Med"},{"issue":"1","key":"4935_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00296-010-1601-4","volume":"32","author":"F Lian","year":"2012","unstructured":"Lian F, Wang Y, Yang X, Xu H, Liang L (2012) Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience. Rheumatol Int 32(1):189\u2013192. https:\/\/doi.org\/10.1007\/s00296-010-1601-4","journal-title":"Rheumatol Int"},{"issue":"11","key":"4935_CR16","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/1756-185X.13955","volume":"23","author":"Y Ke","year":"2020","unstructured":"Ke Y, Lv C, Xuan W, Wu J, Da Z, Wei H, Zhang M, Tan W (2020) Clinical analysis of macrophage activation syndrome in adult rheumatic disease: a multicenter retrospective study. Int J Rheum Dis 23(11):1488\u20131496. https:\/\/doi.org\/10.1111\/1756-185X.13955","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"4935_CR17","doi-asserted-by":"publisher","first-page":"e0235326","DOI":"10.1371\/journal.pone.0235326","volume":"15","author":"P Di Benedetto","year":"2020","unstructured":"Di Benedetto P, Cipriani P, Iacono D, Pantano I, Caso F, Emmi G et al (2020) Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still\u2019s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort. PLoS ONE 15(7):e0235326. https:\/\/doi.org\/10.1371\/journal.pone.0235326 (eCollection 2020)","journal-title":"PLoS ONE"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:38:39Z","timestamp":1744173519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4935"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04935-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were under the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Approval with the decision no. 49 dated 14 July 2020 was obtained from Eski\u015fehir Osmangazi University Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}